Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan
-
- STATUS
- Recruiting
-
- participants needed
- 232
-
- sponsor
- King Abdullah International Medical Research Center
Summary
To compare different timing of
Description
The investigators aim to compare the effectiveness and safety of two management strategies
currently used in basal
Primary Objective:
To determine if taking basal
Secondary Objectives:
- To estimate the difference between the two groups in
glucose variability - To estimate the difference between the two groups in number of days they needed to brake
their
fast - To assess the difference in glycemic control between the two groups
- To estimate the difference between the two groups in overnight and daytime
hyperglycemia . - To estimate the difference between the two groups in rate of severe
hyperglycemia and /or DKA
It is a multi-center open label randomized study that will take place in the
Variables to be Assessed:
- Patient's demographics including (age, gender, type and duration of
diabetes ), and baseline measurements (weight , height,BMI , ). - Rate of
Hypoglycemic events (as per SMBG records and CGM) in both groups - Number of days
fasting was broken in both groups - Rate of severe hyperglycemic episodes (BG>250mg/dl) or DKA in both groups
- Mean
blood glucose for the month of Ramadan as calculated from sum of each patient's 7-point bloodsugar home measurements in both groups. - Mean 24-hour
blood glucose as measured by acontinuous glucose monitoring devise in both groups. - Mean
fasting blood glucose for the month period as calculated from patients home bloodsugar measurements in both groups. - Mean 2-hour post-prandial
blood glucose for the as calculated from patients home bloodsugar measurements in both groups. Fructosamine andHbA1c level before and after Ramadan in both groups
Results of this study will help fill a current gap of knowledge and may also contribute to the development of future guidelines for the management of type1DM during Ramadan.
Details
Condition |
|
---|---|
Age | 14years - 100years |
Treatment |
Timing of taking |
Clinical Study Identifier | NCT04383990 |
Sponsor | King Abdullah International Medical Research Center |
Last Modified on | 19 February 2024 |
How to participate?
,
Select a site
Enter your location to find study centers near you
study centers available
Send a message
Enter your contact details to connect with study team
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy AnnotationsStudy Notes
Enable the functional cookies in order to view/reply the sharedadd your annotations.
Add a private note
- Select a piece of text from the left.
- Add notes visible only to you.
- Send it to people through a passcode protected link.
Publish Annotation
Are you sure you want to publish the annotation?
Delete AnnotationNote
Are you sure you want to delete the annotationnote?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.